CancerConnect Live Web Chat on Treatment Options for Patients with Liver Cancer

CancerConnect Live Web Chat on Treatment Options for Patients with Liver Cancer

Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer Institute. Both are recognized experts in pancreatic and liver cancers. Click here for Dr. Kuvshinoff’s bio and here for Dr. Iyer’s bio.

Boris Kuvshinoff II, MD, MBA

​Each year in the United States, more than 28,000 people are diagnosed with primary liver cancer. Although long-term survival with liver cancer remains poor, advances in surgery, other liver-directed therapies, and targeted systemic therapies are all contributing to improved outcomes. In addition, advances in supportive care have made liver cancer treatment more tolerable, leading to improved quality of life. Understanding treatment options and how and when to access new and innovative treatment options available through clinical trials is essential in order to achieve the best outcome from liver cancer treatment.

On March 20, 2012 you will have the opportunity to ask the experts, Drs. Boris Kuvshinoff and Renuka Iyer, about treatment options available for liver cancers. They are actively involved in clinical research and continue to lead innovative studies in liver cancers and other gastrointestinal cancers.

Renuka Iyer, MD

​Following the presentation, there will be a live Q&A. Click here to submit a question to Drs. Kuvshinoff and Iyer that will be answered during the Live Web Chat (time permitting). Please note that we will do our best to respond to all questions during the 30-minute live Q&A portion of the program. Thank you for your participation.

The Live Web Chat is not intended to be a substitute for healthcare professional medical advice, diagnosis, or treatment. Speak to your healthcare provider about any questions you may have regarding your health.

Copyright © 2018 CancerConnect. All Rights Reserved.

Comments